IKT
Inhibikase Therapeutics Inc
2.10$
+1.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | |
| 87.5% | 85.2% | 90.3% | 227.4% | 128.0% | 366.4% | 5.4% | 5,227.8% | – | – | |
| 12.5% | 14.8% | 100.0% | -127.4% | 100.0% | 100.0% | 94.6% | -5,127.8% | – | – | |
| 87.5% | 85.2% | 90.3% | 227.4% | 128.0% | 366.4% | 9,749.7% | 5,227.8% | – | – | |
| – | – | 62.3% | 380.2% | 375.6% | 209.9% | 5,036.5% | 2,562.7% | – | – | |
| 75.9% | 119.7% | 52.5% | 507.5% | 403.5% | 476.2% | 14,780.7% | 2,584.2% | – | – | |
| -63.4% | -19.7% | -52.5% | -507.5% | -403.5% | -476.2% | -14,686.2% | -7,712.0% | – | – | |
| 0.0% | 0.0% | 0.8% | 2.2% | 4.2% | 0.6% | 60.3% | 28.6% | – | – | |
| -65.0% | -21.2% | -53.3% | -509.7% | -407.7% | -476.9% | -14,625.9% | -7,304.8% | – | – | |
| -1.6% | -19.7% | -4.0% | 2.2% | 4.2% | 0.6% | -120.6% | -57.2% | – | – | |
| -65.0% | -21.2% | -53.3% | -511.9% | -411.9% | -477.5% | -14,625.9% | -7,304.8% | – | – | |
| – | – | -52.5% | -507.5% | -403.5% | -476.2% | -14,620.4% | -7,236.7% | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.